Diagnosis and prognosis of primary breast cancer
Robertson, J.F.; Evans, A.J.
Quarterly Journal of Nuclear Medicine Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 41(3): 200-210
1997
ISSN/ISBN: 1125-0135 PMID: 9274128 Document Number: 481796
The diagnosis of breast cancer should be made in the context of a multidisciplinary team: preoperative diagnosis can be made in over 90% of patients with symptomatic and screen-detected cancers. A preoperative diagnosis allows patients the opportunity to come to terms with the diagnosis of breast cancer and to consider their treatment options before progressing to therapeutic surgery. Surgery remains the primary therapeutic treatment for operable breast cancer with radiotherapy and systemic therapies as adjuvant treatments. Surgery in addition provides pathological specimens from which important prognostic information may be obtained. The traditional TNM classification in itself is no longer sufficient although there is still considerable prognostic information to be gained in staging patients. However, markers of tumour biology provide prognostic data independent of TNM staging. Both need to be considered in any overall assessment of patient prognosis.